logo
#

Latest news with #Hightower

This Analyst Was Right About Broadcom (AVGO) – Stock Up 50% Since Her Recommendation
This Analyst Was Right About Broadcom (AVGO) – Stock Up 50% Since Her Recommendation

Yahoo

timea day ago

  • Business
  • Yahoo

This Analyst Was Right About Broadcom (AVGO) – Stock Up 50% Since Her Recommendation

In September 2024, Stephanie Link, CIO at Hightower, explained during a program on CNBC why she was buying Broadcom Inc (NASDAQ:AVGO) and said the stock was underappreciated. Over the past eight months, Broadcom Inc (NASDAQ:AVGO) is up over 50%. 'Their AI business in their quarter grew threefold year over year. Their VMware business is growing 4 billion on a revenue run rate basis. Those two pieces within Broadcom represent over 50% of total revenues. And then add on at Goldman conference, they're very, very bullish about their business and they're reiterating all kinds of great targets. I mean, their AI business at the beginning of this year, Scott, was $7.5 billion—that was their target for the full year in AI. They're now at 12 billion, and that's just these numbers are crazy, they're great. And so for me, when it fell last Friday 10%, on Monday I added to it. I added again to it yesterday because I don't think it's fully appreciated because I think everybody gives all the credit in the world to Nvidia, which they should. It's a wonderful company, been a great stock, but there are other names to play as well, especially when I don't think it is as appreciated in the marketplace,' Link said at the time. A technician working at a magnified microscope, developing a new integrated circuit. Sands Capital Select Growth Strategy stated the following regarding Broadcom Inc. (NASDAQ:AVGO) in its Q1 2025 investor letter: 'Broadcom Inc. (NASDAQ:AVGO) is a key enabler of systems scalability and compute growth via ethernet networking and custom accelerators. We believe Broadcom will benefit from advancements in AI models in conjunction with increases in computing power, also known as scaling laws. Broadcom supports advances in computing power by providing high bandwidth, low-latency networking solutions. Its solutions help relieve bottlenecks in scaling computing power as an increasing number of semiconductor chips work in parallel for AI training and inference. We expect Broadcom's ethernet switches used for networking to be the primary driver of incremental growth as it benefits from both share increases and demand for larger server clusters that will require better networking solutions. Complementing its networking business, Broadcom is the largest provider of custom chip design services by revenue. These services enable businesses to take greater control of their technology stack, reduce reliance on third-party suppliers, and optimize costs and energy efficiency.' While we acknowledge the potential of AVGO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

UnitedHealth Is Cutting Medicare Advantage Commissions. How Should You Play UNH Stock Here?
UnitedHealth Is Cutting Medicare Advantage Commissions. How Should You Play UNH Stock Here?

Yahoo

time5 days ago

  • Business
  • Yahoo

UnitedHealth Is Cutting Medicare Advantage Commissions. How Should You Play UNH Stock Here?

UnitedHealth (UNH) shares are in focus on Tuesday following reports the health insurance giant is removing commissions for brokers on a small percentage of Medicare Advantage plans. The company believes removing incentives tied to selling these plans could cut costs that made it suspend its full-year guidance last month. Dear Tesla Stock Fans, Mark Your Calendars for June 22 Nvidia Says Quantum Computing Is Nearing an 'Inflection Point.' Here Are the 3 Best Stocks to Buy Now to Profit. Warren Buffett Loves This Cheap Dividend Stock and So Do Company Insiders Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. At the time of writing, UnitedHealth stock is down nearly 50% versus its year-to-date high in April. Removing broker incentives may prove significantly positive for UNH shares since it may reduce enrollment in higher-cost plans, helping the insurer regain control over its margins. Investors could read the company's decision as a proactive step toward stabilizing its earnings and restoring financial discipline. While regulatory pressures remain, cost containment measures like this could ease concerns and support the case for a rebound in UnitedHealth stock – especially as the NYSE-listed firm continues to lead the fast-growing Medicare Advantage market. UNH currently pays a dividend yield of 2.87%, which makes up for another good reason to have it in your investment portfolio. Speaking with CNBC today, Hightower's chief investment strategist Stephanie Link also dubbed the Medicare Advantage news a positive since it's 'what got them in trouble in the first place.' Link agreed that the next few months will likely remain volatile for UNH stock – but reiterated her constructive view on the insurance behemoth for the long term. According to the Hightower's top strategist, UnitedHealth shares are currently going for about 13 times earnings only, which she said was 'too cheap for the number one player in the industry.' Additionally, Link expects UNH to soon announce an extended share repurchase program that she believes could breathe new life into the healthcare stock in the back half of 2025. Despite ongoing challenges and a massive crash in UnitedHealth stock this year, Wall Street hasn't thrown in the towel on the world's largest health insurer. The consensus rating on UNH currently sits at 'Moderate Buy' with the mean target of about $364 indicating potential upside of 18% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio

UnitedHealth Is Cutting Medicare Advantage Commissions. How Should You Play UNH Stock Here?
UnitedHealth Is Cutting Medicare Advantage Commissions. How Should You Play UNH Stock Here?

Yahoo

time5 days ago

  • Business
  • Yahoo

UnitedHealth Is Cutting Medicare Advantage Commissions. How Should You Play UNH Stock Here?

UnitedHealth (UNH) shares are in focus on Tuesday following reports the health insurance giant is removing commissions for brokers on a small percentage of Medicare Advantage plans. The company believes removing incentives tied to selling these plans could cut costs that made it suspend its full-year guidance last month. Dear Tesla Stock Fans, Mark Your Calendars for June 22 Nvidia Says Quantum Computing Is Nearing an 'Inflection Point.' Here Are the 3 Best Stocks to Buy Now to Profit. Warren Buffett Loves This Cheap Dividend Stock and So Do Company Insiders Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. At the time of writing, UnitedHealth stock is down nearly 50% versus its year-to-date high in April. Removing broker incentives may prove significantly positive for UNH shares since it may reduce enrollment in higher-cost plans, helping the insurer regain control over its margins. Investors could read the company's decision as a proactive step toward stabilizing its earnings and restoring financial discipline. While regulatory pressures remain, cost containment measures like this could ease concerns and support the case for a rebound in UnitedHealth stock – especially as the NYSE-listed firm continues to lead the fast-growing Medicare Advantage market. UNH currently pays a dividend yield of 2.87%, which makes up for another good reason to have it in your investment portfolio. Speaking with CNBC today, Hightower's chief investment strategist Stephanie Link also dubbed the Medicare Advantage news a positive since it's 'what got them in trouble in the first place.' Link agreed that the next few months will likely remain volatile for UNH stock – but reiterated her constructive view on the insurance behemoth for the long term. According to the Hightower's top strategist, UnitedHealth shares are currently going for about 13 times earnings only, which she said was 'too cheap for the number one player in the industry.' Additionally, Link expects UNH to soon announce an extended share repurchase program that she believes could breathe new life into the healthcare stock in the back half of 2025. Despite ongoing challenges and a massive crash in UnitedHealth stock this year, Wall Street hasn't thrown in the towel on the world's largest health insurer. The consensus rating on UNH currently sits at 'Moderate Buy' with the mean target of about $364 indicating potential upside of 18% from current levels. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store